Papers
2009
Published in the International Journal of Cancer
Chang YM, Newton-Bishop JA, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM, Ernstoff MS, Green AC, Gruis NA, Holly EA, Ingvar C, Kanetsky PA, Karagas MR, Marchand LL, Mackie RM, Olsson H, Osterlind A, Rebbeck TR, Reich K, Sasieni P, Siskind V, Swerdlow AJ, Titus-Ernstoff L, Zens MS, Ziegler A, Barrett JH.
A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes.
Int J Cancer. 2009 Jan 15;124(2):420-8.
Published in the British Journal of Dermatology
Cuéllar F, Puig S, Kolm I, Puig-Butille J, Zaballos P, Martí-Laborda R, Badenas C, Malvehy J.
Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers.
Br J Dermatol. 2009 Jan;160(1):48-53.
Published in the International Journal of Cancer
Olsen CM, Zens MS, Stukel TA, Sacerdote C, Chang YM, Armstrong BK, Bataille V, Berwick M, Elwood JM, Holly EA, Kirkpatrick C, Mack T, Bishop JN, Østerlind A, Swerdlow AJ, Zanetti R, Green AC, Karagas MR, Whiteman DC.
Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis
Int J Cancer. 2009 Feb 15;124(4):937-44.
Published in the European Journal of Cancer
Galore-Haskel G, Azizi E, Mohamdi H, Scope A, Chaudru V, Laitman Y, Barak F, Pavlotsky F, Demenais F, Friedman E.
MC1R variant alleles and malignant melanoma risk in Israel.
Eur J Cancer. 2009 Mar 5. [Epub ahead of print]
Published in the Journal of Medical Ethics
Affleck PG
Is it ethical to deny genetic research participants individualised results?
J Med Ethics. 2009 Apr;35(4):209-13.
Published in the International Journal of Epidemiology
Chang YM, Barrett JH, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM, Ernstoff MS, Gallagher RP, Green AC, Gruis NA, Holly EA, Ingvar C, Kanetsky PA, Karagas MR, Lee TK, Le Marchand L, Mackie RM, Olsson H, Østerlind A, Rebbeck TR, Sasieni P, Siskind V, Swerdlow AJ, Titus-Ernstoff L, Zens MS, Newton-Bishop JA.
Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls
Int J Epidemiol. 2009 Jun;38(3):814-30.
Published in the European Journal of Cancer
Randerson-Moor JA, Taylor JC, Elliott F, Chang YM, Beswick S, Kukalizch K, Affleck P, Leake S, Haynes S, Karpavicius B, Marsden J, Gerry E, Bale L, Bertram C, Field H, Barth JH, Silva ID, Swerdlow A, Kanetsky PA, Barrett JH, Bishop DT, Bishop JA.
Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data.
Eur J Cancer. 2009 Jul 15. Epub ahead of print.
Published in Nature Genetics
Falchi M, Bataille V, Hayward NK, Duffy DL, Bishop JA, Pastinen T, Cervino A, Zhao ZZ, Deloukas P, Soranzo N, Elder DE, Barrett JH, Martin NG, Bishop DT, Montgomery GW, Spector TD.
Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi.
Nat Genet. 2009 Aug;41(8):915-9. Epub 2009 Jul 5.
Published in Nature Genetics
Bishop DT, Demenais F, Iles MM, Harland M, Taylor JC, Corda E, Randerson-Moor J, Aitken JF, Avril MF, Azizi E, Bakker B, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Chin-A-Woeng T, Debniak T, Galore-Haskel G, Ghiorzo P, Gut I, Hansson J, Hocevar M, Höiom V, Hopper JL, Ingvar C, Kanetsky PA, Kefford RF, Landi MT, Lang J, Lubi?ski J, Mackie R, Malvehy J, Mann GJ, Martin NG, Montgomery GW, van Nieuwpoort FA, Novakovic S, Olsson H, Puig S, Weiss M, van Workum W, Zelenika D, Brown KM, Goldstein AM, Gillanders EM, Boland A, Galan P, Elder DE, Gruis NA, Hayward NK, Lathrop GM, Barrett JH, Bishop JA.
Genome-wide association study identifies three loci associated with melanoma risk
Nat Genet. 2009 Aug;41(8):920-5.
2008
Published in the International Journal of Cancer
Chang YM, Newton-Bishop JA, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM, Ernstoff MS, Green AC, Gruis NA, Holly EA, Ingvar C, Kanetsky PA, Karagas MR, Marchand LL, Mackie RM, Olsson H, Osterlind A, Rebbeck TR, Reich K, Sasieni P, Siskind V, Swerdlow AJ, Titus-Ernstoff L, Zens MS, Ziegler A, Barrett JH. A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. Int J Cancer. 2008 Sep 12. [Epub ahead of print]
Published in the European Journal of Cancer
Beswick S, Affleck P, Elliott F, Gerry E, Boon A, Bale L, Nolan C, Barrett JH, Bertram C, Marsden J, Bishop DT, Newton-Bishop JA.
Environmental risk factors for relapse of melanoma. Eur J Cancer. 2008 Aug;44(12):1717-25.
Published in the Journal of Investigative Dermatology
Cook AL, Chen W, Thurber AE, Smit DJ, Smith AG, Bladen TG, Brown DL, Duffy DL, Pastorino L, Bianchi-Scarra G, Leonard JH, Stow JL, Sturm RA. Analysis of Cultured Human Melanocytes Based on Polymorphisms within the SLC45A2/MATP, SLC24A5/NCKX5, and OCA2/P Loci. J Invest Dermatol. 2008 Jul 24
Published in brief communications, Nature Genetics.
Brown KM, Macgregor S, Montgomery GW, Craig DW, Zhao ZZ, Iyadurai K, K Henders A, Homer N, Campbell MJ, Stark M, Thomas S, Schmid H, Holland EA, Gillanders EM, Duffy DL, Maskiell JA, Jetann J, Ferguson M, Stephan DA, Cust AE, Whiteman D, Green A, Olsson H, Puig S, Ghiorzo P, Hansson J, Demenais F, Goldstein AM, Gruis NA, Elder DE, Bishop JN, Kefford RF, Giles GG, Armstrong BK, Aitken JF, Hopper JL, Martin NG, Trent JM, Mann GJ, Hayward NK. Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat Genet. 2008 Jul;40(7):838-40.
Published in: Cancer Epidemiology Biomarkers Prevention
Kerstann KF, Bradford PT, Steighner R, Calista D, Fargnoli MC, Peris K, Scaini MC, Menin C, Ghiorzo P, Bianchi-Scarra’ G, Goldstein AM, Landi MT. No evidence for linkage with melanoma in Italian melanoma-prone families. Cancer Epidemiol Biomarkers Prev. 2008 Jul;1
Published in the European Journal of Cancer
Harland M, Goldstein AM, Kukalizch K, Taylor C, Hogg D, Puig S, Badenas C, Gruis N, Ter Huurne J, Bergman W, Hayward NK, Stark M, Tsao H, Tucker MA, Landi MT, Scarra GB, Ghiorzo P, Kanetsky PA, Elder D, Mann GJ, Holland EA, Bishop DT, Newton Bishop J; members of GenoMEL, the Melanoma Genetics Consortium. A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL). Eur J Cancer. 2008 Jun;44(9):1269-1274.
Published in the Journal of the National Cancer Institute
Freedberg DE, Rigas SH, Russak J, Gai W, Kaplow M, Osman I, Turner F, Randerson-Moor JA, Houghton A, Busam K, Timothy Bishop D, Bastian BC, Newton-Bishop JA, Polsky D. Frequent p16-independent inactivation of p14ARF in human melanoma. J Natl Cancer Inst. 2008 Jun 4;100(11):784-95.
2007
Published in the Journal Lancet Oncology
Bishop, J. N., Harland, M., Randerson-Moor, J., and Bishop, D. T. (2007).Management of familial melanoma. Lancet Oncol 8(1), 46-54.
Published in the Journal of Investigative Dermatology
Bishop, J. A., Taylor, T., Potts, H. W., Elliott, F., Pinney, E., Barrett, J. H., Bishop, D. T., and Fallowfield, L. (2007). Sun-protective behaviors in families at increased risk of melanoma. J Invest Dermatol 127(6), 1343-50.
Published in the Journal of Medical Genetics
Goldstein, A. M., Chan, M., Harland, M., Hayward, N. K., Demenais, F., Bishop, D. T., Azizi, E., Bergman, W., Bianchi-Scarra, G., Bruno, W., Calista, D., Albright, L. A., Chaudru, V., Chompret, A., Cuellar, F., Elder, D. E., Ghiorzo, P., Gillanders, E. M., Gruis, N. A., Hansson, J., Hogg, D., Holland, E. A., Kanetsky, P. A., Kefford, R. F., Landi, M. T., Lang, J., Leachman, S. A., MacKie, R. M., Magnusson, V., Mann, G. J., Bishop, J. N., Palmer, J. M., Puig, S., Puig-Butille, J. A., Stark, M., Tsao, H., Tucker, M. A., Whitaker, L., and Yakobson, E. (2007). Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet 44(2), 99-106. 2007
Published in Melanoma Research
Pjanova, D., Engele, L., Randerson-Moor, J. A., Harland, M., Bishop, D. T., Newton Bishop, J. A., Taylor, C., Debniak, T., Lubinski, J., Kleina, R., and Heisele, O. (2007).CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population.Melanoma Res 17(3), 185-91. 2007
Published in Epidemiology
Seminara, D., Khoury, M. J., O’Brien, T. R., Manolio, T., Gwinn, M. L., Little, J., Higgins, J. P., Bernstein, J. L., Boffetta, P., Bondy, M., Bray, M. S., Brenchley, P. E., Buffler, P. A., Casas, J. P., Chokkalingam, A. P., Danesh, J., Davey Smith, G., Dolan, S., Duncan, R., Gruis, N. A., Hashibe, M., Hunter, D., Jarvelin, M. R., Malmer, B., Maraganore, D. M., Newton-Bishop, J. A., Riboli, E., Salanti, G., Taioli, E., Timpson, N., Uitterlinden, A. G., Vineis, P., Wareham, N., Winn, D. M., Zimmern, R., and Ioannidis, J. P. (2007). The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology 18(1), 1-8. 2007
Published in the International Journal of Cancer
Goldstein AM, Chaudru V, Ghiorzo P, Badenas C, Malvehy J, Pastorino L, Laud K, Hulley B, Avril MF, Puig-Butille JA, Miniere A, Marti R, Chompret A, Cuellar F, Kolm I, Mila M, Tucker MA, Demenais F, Bianchi-Scarra G, Puig S, de-Paillerets BB. Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries. Int J Cancer.2007 Aug 15;121(4):825-31
Published in Genes Chromosomes Cancer
Lang J, Hayward N, Goldgar D, Tsao H, Hogg D, Palmer J, Stark M, Tobias ES, MacKie R. The M53I mutation in CDKN2A is a founder mutation that predominates in melanoma patients with Scottish ancestry.Genes Chromosomes Cancer. 2007 Mar;46(3):277-87.
Published in the Journal of Medical Genetics
Goldstein AM, Chan M, Harland M, Hayward NK, Demenais F, Bishop DT, Azizi E, Bergman W, Bianchi-Scarra G, Bruno W, Calista D, Albright LA, Chaudru V, Chompret A, Cuellar F, Elder DE, Ghiorzo P, Gillanders EM, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, MacKie RM, Magnusson V, Mann GJ, Bishop JN, Palmer JM, Puig S, Puig-Butille JA, Stark M, Tsao H, Tucker MA, Whitaker L, Yakobson E; Lund Melanoma Study Group; Melanoma Genetics Consortium (GenoMEL). Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents. J Med Genet 2007 Feb;44(2):99-106.
2006
Published in Human Molecular Genetics
Ghiorzo P, Gargiulo S, Pastorino L, Nasti S, Cusano R, Bruno W, Gliori S, Sertoli MR, Burroni A, Savarino V, Gensini F, Sestini R, Queirolo P, Goldstein AM, Scarrà GB.Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma
Hum Mol Genet. 2006 Sep 15;15(18):2682-9.
Published in Cancer Research
Goldstein AM, Chan M, Harland M, Gillanders EM, Hayward NK, Avril MF, Azizi E, Bianchi-Scarra G, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cannon Albright LA, Demenais F, Elder DE, Ghiorzo P, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, Mackie RM, Magnusson V, Mann GJ, Niendorf K, Newton Bishop J, Palmer JM, Puig S, Puig-Butille JA, de Snoo FA, Stark M, Tsao H, Tucker MA, Whitaker L, Yakobson E; Melanoma Genetics Consortium (GenoMEL). Assessment of high-risk melanoma susceptibility genes and their associations with pancreatic cancer, neural system tumors, and uveal melanoma: A Melanoma Genetics Consortium (GenoMEL) study
Cancer Res 2006; 66(20): 9818-28
Acta Universitatis Latviensis
D.Pjanova O.Heisele, L.Engele, J.A.Randerson-Moor, K.Kukalizch, T.Bishop, J.A.Newton Bishop. Analysis of Latvian familial melanoma patients for 9p21 germline deletions by multiplex ligation-dependent probe amplification approach. Acta Universitatis Latviensis, 2006, Nov.
2005
Published in Genes Chromosomes Cancer
Molven A, Grimstvedt MB, Steine SJ, Harland M, Avril MF, Hayward NK, Akslen LA. A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. Genes Chromosomes Cancer. 2005 Sep;44(1):10-8.
Published in Oncogene
Harland M, Taylor CF, Chambers PA, Kukalizch K, Randerson-Moor JA, Gruis NA, de Snoo FA, ter Huurne JA, Goldstein AM, Tucker MA, Bishop DT, Bishop JA. A mutation hotspot at the p14ARF splice site.
Oncogene. 2005 Jun 30;24(28):4604-8.
Published in Genes Chromosomes Cancer
Harland M, Taylor CF, Bass S, Churchman M, Randerson-Moor JA, Holland EA, Mann GJ, Bishop DT, Newton Bishop JA. Intronic sequence variants of the CDKN2A gene in melanoma pedigrees.
Genes Chromosomes Cancer. 2005 Jun;43(2):128-36.
2003
Published in American Journal of Human Genetics
Gillanders, E.; Hank Juo, S. H.; Holland, E. A.; Jones, M.; Nancarrow, D.; Freas-Lutz, D.; Sood, R.; Park, N.; Faruque, M.; Markey, C.; Kefford, R. F.; Palmer, J.; Bergman, W.; Bishop, D. T.; Tucker, M. A.; Bressac-de Paillerets, B.; Hansson, J.; Stark, M.; Gruis, N.; Bishop, J. N.; Goldstein, A. M.; Bailey-Wilson, J. E.; Mann, G. J.; Hayward, N.; Trent, J. Localization of a novel melanoma susceptibility locus to 1p22
Am J Hum Genet. 73(2): 301-13, 2003
Published in Human Mutation
Fung, D. C.; Holland, E. A.; Becker, T. M.; Hayward, N. K.; Bressac-de Paillerets, B.; Mann, G. J. eMelanoBase: an online locus-specific variant database for familial melanoma
Hum Mutat 21(1): 2-7, 2003
2002
Journal of the National Cancer Institute
Bishop, D. T.; Demenais, F.; Goldstein, A. M.; Bergman, W.; Bishop, J. N.; Bressac-de Paillerets, B.; Chompret, A.; Ghiorzo, P.; Gruis, N.; Hansson, J.; Harland, M.; Hayward, N.; Holland, E. A.; Mann, G. J.; Mantelli, M.; Nancarrow, D.; Platz, A.; Tucker, M. A. Geographical variation in the penetrance of CDKN2A mutations for melanoma J Natl Cancer Inst 94(12): 894-903. 2002
Published in Lancer Oncology
Kefford, R.; Bishop, J. N.; Tucker, M.; Bressac-de Paillerets, B.; Bianchi-Scarra, G.; Bergman, W.; Goldstein, A.; Puig, S.; Mackie, R.; Elder, D.; Hansson, J.; Hayward, N.; Hogg, D.; Olsson, H. Genetic testing for melanoma
Lancet Oncol 3(11): 653-4, 2002
Published in Genes Chromosomes Cancer
Harland M, Holland EA, Ghiorzo P, Mantelli M, Bianchi-Scarrà G, Goldstein AM, Tucker MA, Ponder BA, Mann GJ, Bishop DT, Newton Bishop J.
Mutation screening of the CDKN2A promoter in melanoma families.
Genes Chromosomes Cancer. 2000 May;28(1):45-57.
2000
Published by Genes Chromosomes Cancer
Harland, M.; Holland, E. A.; Ghiorzo, P.; Mantelli, M.; Bianchi-Scarra, G.; Goldstein, A. M.; Tucker, M. A.; Ponder, B. A.; Mann, G. J.; Bishop, D. T.; Newton Bishop, J.Mutation screening of the CDKN2A promoter in melanoma families Genes Chromosomes Cancer 28(1): 45-57, 2000
1999
Published in the Journal of Clinical Oncology
Kefford, R. F.; Newton Bishop, J. A.; Bergman, W.; Tucker, M. A.
Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium J Clin Oncol 17: 10, 1999.
Published in the British Journal of Cancer
Newton Bishop JA, Harland M, Bennett DC, Bataille V, Goldstein AM, Tucker MA, Ponder BA, Cuzick J, Selby P, Bishop DT. Mutation testing in melanoma families: INK4A, CDK4 and INK4D. Br J Cancer. 1999 Apr;80(1-2):295-300.